Cefoperazone: Difference between revisions
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
'''| [[cefoperazone warnings and precautions|Warnings and Precautions]]''' | '''| [[cefoperazone warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[cefoperazone adverse reactions|Adverse Reactions]]''' | '''| [[cefoperazone adverse reactions|Adverse Reactions]]''' | ||
'''| [[cefoperazone dosage and administration|Dosage and Administration]]''' | '''| [[cefoperazone dosage and administration|Dosage and Administration]]''' | ||
'''| [[cefoperazone Compatibility and Stability|Compatibility and Stability]]''' | '''| [[cefoperazone Compatibility and Stability|Compatibility and Stability]]''' | ||
Revision as of 06:09, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Overview
Cefoperazone is a third generation cephalosporin antibiotic. Marketed by pfizer under the name Cefobid®.
Cefina-SB is a combination of sulbactam and cefoperazone. Cefoperazone exerts its bactericidal effect by inhibiting the bacterial cell wall synthesis, and sulbactam acts as a beta-lactamase inhibitor, to increase the antibacterial activity of cefoperazone against beta-lactamase producing organisms. Cefina-SB is available as injection for the treatment of bacterial infections. In some countries, the combination is sold as Sulperazone. Cefoperazone is available in the United States as Cefobid.
Category
Cephalosporins, third generation.
US Brand Names
CEFOBID®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Dosage and Administration | Compatibility and Stability | How Supplied | Labels and Packages
References
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6c2ef3b-2c53-4737-9f7d-2d7e040c6e87